Gene discovery to improve drug safety
06 June, 2012Researchers from Murdoch University have assisted in a groundbreaking discovery which could lead to the dramatic improvement of drug safety.
‘Next generation’ cancer treatment ready for clinical trials
21 May, 2012A new class of anticancer drugs which control the growth and spread of cancers and do so with minimal side effects is being developed by researchers at the University of Sydney.
Early biomarker for pancreatic cancer identified
17 May, 2012Following the discovery by Mayo Clinic scientists of biomarkers for prostate cancer, researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention.
Designer medicines beat the ‘food factor’
16 May, 2012Researchers at the University of South Australia’s Ian Wark Research Institute and Monash Institute of Pharmaceutical Science at Monash University have cracked a way to use innovative nanotechnologies to ensure disease-controlling drugs are absorbed in the body much more efficiently.
Biomarkers found for prostate cancer detection, recurrence
16 May, 2012Alterations to the ‘on-off’ switches of genes occur early in the development of prostate cancer and could be used as biomarkers to detect the disease months or even years earlier than current approaches, a Mayo Clinic study has found.
Italian researchers make a major discovery into a common form of muscular dystrophy
11 May, 2012A new study, published in the international scientific journal Cell, has identified that a novel defect in gene regulation, never before seen in a human disease, is the cause of one of the most common forms of muscular dystrophy: Facioscapulohumeral muscular dystrophy (FSHD).
Interacting light with matter - new tools for early cancer detection
03 May, 2012A research team at the University of Adelaide, led by Professor Tanya Monro, is working to create a whole range of new high-tech tools that use light for measuring, including new devices for early detection of cancer and smart bungs that monitor wine quality.
Researchers discover genes for fracture susceptibility and osteoporosis risk
30 April, 2012Researchers from the University of Queensland (UQ) Diamantina Institute have played a leading role in a recent study into osteoporosis, more than doubling the number of currently known genes in the disease.
WA expert helps lead world diagnosis of rare disorder in newborn babies
27 April, 2012A Western Australian-based expert in neuromuscular diseases has helped revolutionise the way doctors around the world diagnose muscle dysfunction in newborn babies.
Scientists discover new fat over lunch
18 April, 2012Uncovering new fats, or lipids, with links to diseases in the human eye (lens) is as easy as taking a lunch break, according to chemists from the ARC Centre of Excellence for Free Radical Chemistry and Biotechnology at the University of Wollongong.
Study identifies optimal gene targets for new colon cancer test
04 April, 2012A study presented by Mayo Clinic researchers at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago has identified two genes that are optimal targets to be analysed in a new noninvasive test for colorectal cancer.
Newcastle scientists one step closer to Alzheimer’s blood test
03 April, 2012An interdisciplinary team of scientists at the University of Newcastle has shown the potential of a simple blood-based test to identify people in the early stages of Alzheimer’s disease, before any symptoms appear.
Gold used as safe driver of cancer drug
22 March, 2012Gold nanoparticles can be used as delivery vehicles for platinum anticancer drugs, improving targeting and uptake into cells, according to research published in this month’s edition of the international journal Inorganic Chemistry.
Study reveals contraceptive cancer risks
07 March, 2012A study has revealed that injectable contraceptives that are widely used around the world influence the risk of developing several types of cancer. The study builds on previous research which found that women using oral contraception have a temporarily increased risk of breast cancer and cervical cancer and a decreased risk of ovarian cancer and cancer of the lining of the womb.
Shark blood holds potential for new antibody technology
05 March, 2012Australian research into shark antibodies that holds out the potential for new drugs and diagnostic agents is a step closer to realising its goal following an agreement with international diagnostic and pharmaceutical giant Roche. The pioneering work, which has attracted worldwide interest, is based on research led by Associate Professor Michael Foley at the La Trobe Institute of Molecular Science (LIMS).
